A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
5-androstenedione
Opipramol
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Opipramol.
5-androstenedione
Oxaprotiline
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Oxaprotiline.
5-androstenedione
Tianeptine
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Tianeptine.
5-androstenedione
Dimetacrine
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Dimetacrine.
5-androstenedione
Amineptine
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Amineptine.
5-androstenedione
Cortisone
The risk or severity of adverse effects can be increased when Cortisone is combined with Pitolisant.
5-androstenedione
Cloprednol
The risk or severity of adverse effects can be increased when Cloprednol is combined with Pitolisant.
5-androstenedione
Cortivazol
The risk or severity of adverse effects can be increased when Cortivazol is combined with Pitolisant.
5-androstenedione
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Pitolisant.
5-androstenedione
Flurbiprofen axetil
The risk or severity of adverse effects can be increased when Flurbiprofen axetil is combined with Pitolisant.
5-androstenedione
NS-398
The risk or severity of adverse effects can be increased when NS-398 is combined with Pitolisant.
5-androstenedione
SC-236
The risk or severity of adverse effects can be increased when SC-236 is combined with Pitolisant.
5-androstenedione
Imidazole salicylate
The risk or severity of adverse effects can be increased when Imidazole salicylate is combined with Pitolisant.
5-androstenedione
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Pitolisant.
5-androstenedione
Pirprofen
The risk or severity of adverse effects can be increased when Pirprofen is combined with Pitolisant.
5-androstenedione
Benorilate
The risk or severity of adverse effects can be increased when Benorilate is combined with Pitolisant.
5-androstenedione
Proquazone
The risk or severity of adverse effects can be increased when Proquazone is combined with Pitolisant.
5-androstenedione
Mofebutazone
The risk or severity of adverse effects can be increased when Mofebutazone is combined with Pitolisant.
5-androstenedione
Carbaspirin calcium
The risk or severity of adverse effects can be increased when Carbaspirin calcium is combined with Pitolisant.
5-androstenedione
Ethenzamide
The risk or severity of adverse effects can be increased when Ethenzamide is combined with Pitolisant.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3